Concourse Financial Group Securities, Inc. Rocket Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$11.35 - $18.82 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$17.6 - $25.88 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$20.66 - $26.72 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$26.16 - $30.74 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$16.78 - $31.94 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$15.07 - $24.05 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$15.07 - $24.05 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$16.59 - $23.6 $0 - $0
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$15.5 - $22.76 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$12.37 - $18.41 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$7.96 - $16.64 $0 - $0
Q1 2022 May 09, 2022	BUY	$13.16 - $23.68 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$21.52 - $36.02 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$27.42 - $48.97 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$39.41 - $47.25 $0 - $0
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$23.3 - $59.57 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$20.5 - $28.59 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $0 - $0
Q1 2020 May 13, 2020	BUY	$9.71 - $25.11 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$10.85 - $14.78 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.81 $0 - $0
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$18.5 - $25.49 $0 - $0

Others Institutions Holding RCKT

# of Institutions

243

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

Rtw Investments, LP New York, NY

17.7M
Shares

$191 Million
3.63% of portfolio
Wellington Management Group LLP Boston, MA

14M
Shares

$151 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

6.58M
Shares

$71 Million
0.0% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$66.9 Million
0.0% of portfolio
Lee Ainslie Maverick Capital LTD | Dallas, Tx

5.2M
Shares

$56.1 Million
1.26% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $817M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account